KCP
EW icon

Kera Capital Partners’s Edwards Lifesciences EW Stock Holding History

Kera Capital Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$884K Buy
9,774
+3,148
+48% +$264K 0.08% 152
2026
Q1 		$531K Buy
6,626
+620
+10% +$51.1K 0.07% 228
2025
Q4 		$489K Buy
6,006
+488
+9% +$40K 0.06% 254
2025
Q3 		$429K Buy
5,518
+1,773
+47% +$139K 0.06% 184
2025
Q2 		$293K Buy
3,745
+655
+21% +$48.9K 0.06% 201
2025
Q1 		$224K Buy
3,090
+148
+5% +$10.6K 0.07% 164
2024
Q4 		$218K Buy
+2,942
New +$206K 0.06% 129

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Kera Capital Partners's EW Position: Q2 2026 in Review

Kera Capital Partners increased its Edwards Lifesciences (EW) stake by 48% in Q2 2026, buying an estimated $264K and bringing the position to 9,774 shares worth $884K. The position accounts for 0.08% of the portfolio, ranked #152.

Kera Capital Partners first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Kera Capital Partners held 9,774 shares of Edwards Lifesciences worth $884K as of Q2 2026.
  • Kera Capital Partners bought 3,148 Edwards Lifesciences shares in Q2 2026, an estimated $264K.
  • Edwards Lifesciences made up 0.08% of Kera Capital Partners's portfolio in Q2 2026, its #152 holding.
  • Kera Capital Partners first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.